Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors

被引:10
作者
Song, Fei [1 ,2 ,3 ]
Bandara, Manoj [1 ]
Deol, Harvinder [1 ]
Loeb, Jeffrey A. [1 ,2 ]
Benjamins, Joyce [1 ,3 ]
Lisak, Robert P. [1 ,3 ]
机构
[1] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA
[2] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[3] Wayne State Univ, Dept Immunol & Microbiol, Detroit, MI 48201 USA
关键词
Experimental autoimmune encephalomyelitis; Multiple sclerosis; BDNF and TrkB tyrosine kinase receptor; Neuregulin1; Glatiramer acetate; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GLATIRAMER ACETATE TREATMENT; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ENHANCES REMYELINATION; NEUREGULIN EXPRESSION; SPINAL-CORD; T-CELLS; DEMYELINATION; RECEPTOR;
D O I
10.1016/j.jneuroim.2013.05.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Soluble factors that promote survival and differentiation of glia and neurons during development are likely to play key roles in neurodegeneration and demyelinating diseases such as multiple sclerosis (MS) and have the potential to be important therapeutic targets. We examined the effect of TrkB signaling and the expression patterns of neurotrophic and gliotrophic factors in the mouse brain in MOG-induced experimental allergic encephalomyelitis (EAE). With induction of mild disease, TrkB heterozygous mice were more severely affected compared to their wild type littermates. However, with more potent disease induction, TrkB heterozygotes fared similar to their wild type littermates, suggesting complex modulatory roles for TrkB signaling. One possible explanation for this difference is that the expression patterns of neurotrophic factors correlate with disease severity in individual mice with mild disease, but not in more severe disease. With the less potent induction in C57BL/6 mice, we found that BDNF was consistently increased at EAE onset, while the soluble gliotrophic factor neuregulin (NRG1) was increased only in the chronic phase of the disease. Treatment of these animals with glatiramer acetate (GA) to decrease disease severity resulted in lower levels of both BDNF and NRG1 expression in some mice at 35 days after immunization compared to those in untreated EAR mice, but had no direct effect on these factors in the absence of EAE. Our results suggest a complex interplay between neurotrophic and gliotrophic factors in EAE that is dependent on disease stage and severity. While signaling by BDNF through TrkB is protective in mild disease, this effect was not seen in more severe disease. The late induction of NRG1 in the chronic stage of disease could also worsen disease severity through its known ability to activate microglial, inflammatory pathways. While complex, these studies begin to define underlying axoglial trophic activities that are likely involved in both disease pathogenesis and repair. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 48 条
[1]   The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice [J].
Aharoni, R ;
Eilam, R ;
Domev, H ;
Labunskay, G ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (52) :19045-19050
[2]   Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis [J].
Aharoni, Rina ;
Herschkovitz, Avia ;
Eilam, Raya ;
Blumberg-Hazan, Michal ;
Sela, Michael ;
Bruck, Wolfgang ;
Arnon, Ruth .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (32) :11358-11363
[3]   Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis [J].
Aharoni, Rina ;
Saada, Ravit ;
Eilam, Raya ;
Hayardeny, Liat ;
Sela, Michael ;
Arnon, Ruth .
JOURNAL OF NEUROIMMUNOLOGY, 2012, 251 (1-2) :14-24
[4]   Inflammation in neurodegenerative diseases [J].
Amor, Sandra ;
Puentes, Fabiola ;
Baker, David ;
van der Valk, Paul .
IMMUNOLOGY, 2010, 129 (02) :154-169
[5]   p75(NTR) and apoptosis: Trk-dependent and Trk-independent effects [J].
Bredesen, DE ;
Rabizadeh, S .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :287-290
[6]   The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits [J].
Buonanno, Andres .
BRAIN RESEARCH BULLETIN, 2010, 83 (3-4) :122-131
[7]   Neuregulin-ErbB Signaling Promotes Microglial Proliferation and Chemotaxis Contributing to Microgliosis and Pain after Peripheral Nerve Injury [J].
Calvo, Margarita ;
Zhu, Ning ;
Tsantoulas, Christoforos ;
Ma, Zhenzhong ;
Grist, John ;
Loeb, Jeffrey A. ;
Bennett, David L. H. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (15) :5437-5450
[8]   Neuregulin and erbB receptor expression in normal and diseased human white matter [J].
Cannella, B ;
Pitt, D ;
Marchionni, M ;
Raine, CS .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :233-242
[9]   The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis [J].
Cannella, B ;
Hoban, CJ ;
Gao, YL ;
Garcia-Arenas, R ;
Lawson, D ;
Marchionni, M ;
Gwynne, D ;
Raine, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10100-10105
[10]  
Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275